Home
About Us
About Imugene
Our People
Vision Statement
Corporate Profile
Linguet Technology
Market Opportunities
Linguet Pipeline
Linguet & Vitamin D
Linguet & Parkinsons Disease
Linguet & Pain Relief
Intellectual Property
Investor Centre
ASX Announcements
ASX Announcements 2013
ASX Announcements 2012
ASX Announcements 2011
ASX Announcements 2010
ASX Announcements 2009
ASX Announcements 2008
ASX Announcements Pre 2008
Annual Reports
Investor Presentations
Research & Analyst Reports
Media Monitoring
Newsletters
Corporate Governance
Contact Us
Annual Reports
2012
Annual Report to shareholders
2011
Annual Report to shareholders
2010
Annual Report to shareholders
2009
Annual Report to shareholders
2008
Annual Report to shareholders
2007
Annual Report to shareholders
2006
Annual Report to shareholders
2005
Annual Report to shareholders
2004
Annual Report to shareholders